Concepedia

R VANSCHAIK

RV

Statistics

Publications

5

Citations

491

H-Index

5

Active since

2004

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

Dutch Health Care Inspectorate

R VANSCHAIK is an author at Erasmus MC specializing in pharmacogenetics, pharmacology, and drug metabolism genetics.

Publications per year

2004–2006

5

Publications

5

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the and genes

Dennis A. Hesselink, T VANGELDER, R VANSCHAIK et al. · Clinical Pharmacology & Therapeutics · 2004 · 172 citations

, , +17

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

Erin R. Gardner, Henry Burger, R VANSCHAIK et al. · Clinical Pharmacology & Therapeutics · 2006 · 144 citations

, , +17

MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine

Albert‐Jan L.H.J. Aarnoudse, R VANSCHAIK, J. Dieleman et al. · Clinical Pharmacology & Therapeutics · 2006 · 76 citations

, , +17

Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants

Loes E. Visser, R VANSCHAIK, M VANVLIET et al. · Clinical Pharmacology & Therapeutics · 2005 · 51 citations

, , +10

ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients

M VANDENHEUVELEIBRINK, R VANSCHAIK, I VANDERHEIDEN et al. · Clinical Pharmacology & Therapeutics · 2006 · 48 citations

, , +13

1–5 of 5